Skin
Cancer Screening Tool Can Help Reduce ‘Worry Time’
These days, a cancer diagnosis—while upsetting and worrisome—is
often no longer a death sentence. According to a recent joint study from Loyola
University in Chicago and Harvard Medical School, regular physical activity in
cancer patients could cut the risk of death nearly in half. However, the best
way to fight cancer will always be early detection followed by aggressive
medical treatment.
When it comes to skin, rather than wait for one’s annual check-up,
it’s important to self-examine and notice if there are changes. Self-screening
for potential skin cancer is easy– just pay attention to skin, particularly
moles, birthmarks or freckles. If any of these change size, color or shape, or
pop up out of the blue, one should take note and tell a dermatologist. It could
be nothing, but better safe than sorry.
Melanomas in particular can metastasize if left unchecked. Caliber
Imaging & Diagnostics (I.D.) is one company that knows the importance of
screening for skin cancer, and is doing something to help. Based in Boston and
Rochester, Caliber I.D. designs, develops and markets innovative imaging
technology for examining skin tissue at the cellular level.
Caliber has created confocal microscopy devices called VivaScope®.
This breakthrough technological advance can take pictures of an entire lesion
layer by layer, and can help physicians to diagnose most skin diseases and
disorders. Since there is no cutting involved, there is also no possibility of
infection or scarring. Obtaining an image takes just a few minutes so the
doctor can make a determination at the bedside, or the image can be transferred
within minutes through the company’s VivaNet® system, so that a pathologist can
diagnose it remotely. This significantly reduces the “worry time” associated
with biopsies.
L. Michael Hone, CEO of Caliber I.D., says, “VivaScope is designed
to help physicians improve the quality of care for patients who want medical
advice about their skin without the disadvantages presented by traditional
biopsy.”





